Print

ImmunoCellular Therapeutics, Ltd to Report Financial Results for the Fourth Quarter and Full Year 2012 on March 5, 2013  
2/26/2013 6:45:32 AM

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that it plans to report fourth quarter and full year 2012 financial results on Tuesday, March 5, 2013. ImmunoCellular will host a conference call and webcast to discuss financial results and provide a business update at 5:00 pm ET that day. The call will be hosted by Andrew Gengos, President and CEO.
//-->